NCT01484327View on ClinicalTrials.gov

Carvedilol Vascular Efficacy Trial

CompletedOBSERVATIONAL
Enrollment

415

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Heart FailureAcute Myocardial Infarction
Interventions
DRUG

Carvedilol

Minimum dosage 3.125 mg Χ 2, Maximum dosage 50 mg

Trial Locations (1)

Unknown

Cardiology University Clinic, Alexandroupoli

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY